Forecasts by Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS), Others), by Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Faecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Neurostimulation Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Favourable Regulatory and Reimbursement Scenario will Accelerate Neurostimulation Devices Market Growth Presence of regulatory bodies such as MHRA and NICE for clinical and safety guidelines and enabling regulatory approval of neurostimulation devices under Class III devices will favour industry growth in the future. Growing focus of regulatory authorities in addressing the need for effective drug development for neurological disorders will accelerate business growth. For instance, Stimwave Technologies was granted the authorization to decide on the reimbursement with healthcare insurers over and above of the DRG payment limits for its chronic pain management products.
Complications Associated with Usage of Neurostimulation Devices The complications in neurostimulation devices are majorly categorized into hardware complications, biological complications, and programming or therapy-related complications. Some of the hardware-related complications include battery depletion, flipping, lead migration, and recharging difficulties. Biological complications include the pain related to device components, wound infections, skin erosion, complications related to device removal, and accidental dural puncture. Programming related complications include loss of paranesthesia or painful paranesthesia. Complications related to programming are not very frequent, however it could result in device removal due to therapy failure. These aforementioned complications act as challenges in the adoption of neurostimulation devices, thereby restraining the growth of the market.
Lack of Skilled Healthcare Practitioners The inadequate number of healthcare practitioners with the required skills to manage and treat neurological diseases will hamper industry growth over the coming years. Treatment and assessment are required to support diagnosis in a few cases. In most of cases, individual test results need to be interpreted carefully that requires skilled expertise. In most of the low and middle-income countries, access to healthcare services is challenging due to financial constraints, there is a shortage of skilled nurses and doctors, neurologists are rare, and neurological diagnostic services are not present. Even when neurological diseases are diagnosed, lack of patient information, and usage of traditional medicine delay the initiation of treatment.
What Questions Should You Ask before Buying a Market Research Report? • How is the Neurostimulation Devices Market evolving? • What is driving and restraining the Neurostimulation Devices Market? • How will each Neurostimulation Devices submarket grow over the forecast period and how much revenue will these submarkets account for in 2033? • How will the market shares for each Neurostimulation Devices submarket develop from 2023 to 2033? • What will be the main driver for the overall market from 2023 to 2033? • Will leading Neurostimulation Devices Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033? • Who are the leading players and what are their prospects over the forecast period? • What are the neurostimulation devices development projects for these leading companies? • How will the industry evolve during the period between 2023 and 2033? What are the implications of neurostimulation devices development projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the Neurostimulation Devices Market? • Where is the Neurostimulation Devices Market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Neurostimulation Devices Market today, and over the next 10 years: • Our 250-page report provides 111 tables and 139 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Neurostimulation Devices Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising neurostimulation devices prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product • Deep Brain Stimulator • Gastric Electric Stimulator • Spinal Cord Stimulator • Sacral Nerve Stimulator • Vagus Nerve Stimulator • Transcutaneous Electrical Nerve Stimulation • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:
North America • U.S. • Canada
Europe • Germany • UK • France • Spain • Italy • Rest of Europe
Asia Pacific • China • Japan • India • Australia • South Korea • Rest of Asia Pacific
Latin America • Brazil • Mexico • Rest of Latin America
The report also includes profiles and for some of the leading companies in the Neurostimulation Devices Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • Abbott Laboratories • Advanced Bionics AG (Sonova) • Boston Scientific Corporation • BrainCo, Inc • Cochlear Limited • ElectroCore Inc. • Helbling Holding AG • Innovative Health Solutions, Inc. • LivaNova PLC • Medtronic • MicroTransponder • Neuronetics, Inc. • Nihon Kohden Corporation • Natus medical Incorporated • Parasym Ltd. • Synapse Biomedical Inc • tVNS Technologies GmbH (Cerbomed)
Overall world revenue for Neurostimulation Devices Market, 2023 to 2033 in terms of value the market will surpass US$9,000 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Neurostimulation Devices Market, 2023 to 2033 report help you? In summary, our 250-page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Neurostimulation Devices Market, 2023 to 2033 Market, with forecasts for Type of Product, Type of Application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Neurostimulation Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Neurostimulation Devices Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Neurostimulation Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Buy our report today Neurostimulation Devices Market Report 2023-2033: Forecasts by Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS), Others), by Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Faecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview 1.1 Objectives of the Study 1.2 Introduction to Neurostimulation Devices Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report for? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.7.3.1 Primary Research 1.7.3.2 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Market Overview 3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 Increasing Prevalence of Neurological Disorders 3.2.1.2 Growing Investments by Companies and Organizations Across the Globe 3.2.1.3 Technological Advancements in Neurostimulation Devices 3.2.2 Market Restraining Factors 3.2.2.1 Complications Associated with Usage of Neurostimulation Devices 3.2.2.2 Lack of Skilled Healthcare Practitioners 3.2.3 Market Opportunities 3.2.3.1 Rising Demand for Minimally Invasive Surgeries in Developed Countries 3.2.3.2 Increasing Number of Elderly Patients with Neurological Disorders 3.3 COVID-19 Impact Analysis 3.4 Porter’s Five Forces Analysis 3.4.1 Bargaining Power of Suppliers 3.4.2 Bargaining Power of Buyers 3.4.3 Competitive Rivalry 3.4.4 Threat from Substitutes 3.4.5 Threat of New Entrants 3.5 PEST Analysis
4 Neurostimulation Devices Market Analysis by Product 4.1 Key Findings 4.2 Product Segment: Market Attractiveness Index 4.3 Neurostimulation Devices Market Size Estimation and Forecast by Product 4.4 Deep Brain Stimulator(DBS) 4.4.1 Market Size by Region, 2023-2033 (US$ Mn) 4.4.2 Market Share by Region, 2023 & 2033 (%) 4.5 Gastric Electric Stimulator(GES) 4.5.1 Market Size by Region, 2023-2033 (US$ Mn) 4.5.2 Market Share by Region, 2023 & 2033 (%) 4.6 Spinal Cord Stimulator(SCS) 4.6.1 Market Size by Region, 2023-2033 (US$ Mn) 4.6.2 Market Share by Region, 2023 & 2033 (%) 4.7 Sacral Nerve Stimulator 4.7.1 Market Size by Region, 2023-2033 (US$ Mn) 4.7.2 Market Share by Region, 2023 & 2033 (%) 4.8 Vagus Nerve Stimulator 4.8.1 Market Size by Region, 2023-2033 (US$ Mn) 4.8.2 Market Share by Region, 2023 & 2033 (%) 4.9 Transcutaneous Electrical Nerve Stimulation (TENS) 4.9.1 Market Size by Region, 2023-2033 (US$ Mn) 4.9.2 Market Share by Region, 2023 & 2033 (%) 4.10 Others 4.10.1 Market Size by Region, 2023-2033 (US$ Mn) 4.10.2 Market Share by Region, 2023 & 2033 (%)
5 Neurostimulation Devices Market Analysis by Application 5.1 Key Findings 5.2 Application Segment: Market Attractiveness Index 5.3 Neurostimulation Devices Market Size Estimation and Forecast by Application 5.4 Pain Management 5.4.1 Market Size by Region, 2023-2033 (US$ Mn) 5.4.2 Market Share by Region, 2023 & 2033 (%) 5.5 Epilepsy 5.5.1 Market Size by Region, 2023-2033 (US$ Mn) 5.5.2 Market Share by Region, 2023 & 2033 (%) 5.6 Essential Tremor 5.6.1 Market Size by Region, 2023-2033 (US$ Mn) 5.6.2 Market Share by Region, 2023 & 2033 (%) 5.7 Urinary and Fecal Incontinence 5.7.1 Market Size by Region, 2023-2033 (US$ Mn) 5.7.2 Market Share by Region, 2023 & 2033 (%) 5.8 Depression 5.8.1 Market Size by Region, 2023-2033 (US$ Mn) 5.8.2 Market Share by Region, 2023 & 2033 (%) 5.9 Dystonia 5.9.1 Market Size by Region, 2023-2033 (US$ Mn) 5.9.2 Market Share by Region, 2023 & 2033 (%) 5.10 Gastroparesis 5.10.1 Market Size by Region, 2023-2033 (US$ Mn) 5.10.2 Market Share by Region, 2023 & 2033 (%) 5.11 Parkinson’s Disease 5.11.1 Market Size by Region, 2023-2033 (US$ Mn) 5.11.2 Market Share by Region, 2023 & 2033 (%) 5.12 Others 5.12.1 Market Size by Region, 2023-2033 (US$ Mn) 5.12.2 Market Share by Region, 2023 & 2033 (%)
6 Neurostimulation Devices Market Analysis by Region 6.1 Key Findings 6.2 Regional Segment: Market Attractiveness Index 6.3 Neurostimulation Devices Market Size Estimation and Forecast
7 North America Neurostimulation Devices Market Analysis 7.1 Key Findings 7.2 North America Neurostimulation Devices Market Attractiveness Index 7.3 North America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn) 7.4 North America Neurostimulation Devices Market Size Estimation and Forecast by Country 7.5 North America Neurostimulation Devices Market Size Estimation and Forecast by Product 7.6 North America Neurostimulation Devices Market Size Estimation and Forecast by Application 7.7 U.S. Neurostimulation Devices Market Analysis 7.8 Canada Neurostimulation Devices Market Analysis
8 Europe Neurostimulation Devices Market Analysis 8.1 Key Findings 8.2 Europe Neurostimulation Devices Market Attractiveness Index 8.3 Europe Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn) 8.4 Europe Neurostimulation Devices Market Size Estimation and Forecast by Country 8.5 Europe Neurostimulation Devices Market Size Estimation and Forecast by Product 8.6 Europe Neurostimulation Devices Market Size Estimation and Forecast by Application 8.7 Germany Neurostimulation Devices Market Analysis 8.8 France Neurostimulation Devices Market Analysis 8.9 UK Neurostimulation Devices Market Analysis 8.10 Italy Neurostimulation Devices Market Analysis 8.11 Spain Neurostimulation Devices Market Analysis 8.12 Russia Neurostimulation Devices Market Analysis 8.13 Rest of Europe Neurostimulation Devices Market Analysis
9 Asia Pacific Neurostimulation Devices Market Analysis 9.1 Key Findings 9.2 Asia Pacific Neurostimulation Devices Market Attractiveness Index 9.3 Asia Pacific Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn) 9.4 Asia Pacific Neurostimulation Devices Market Size Estimation and Forecast by Country 9.5 Asia Pacific Neurostimulation Devices Market Size Estimation and Forecast by Product 9.6 Asia Pacific Neurostimulation Devices Market Analysis by Application 9.7 Japan Neurostimulation Devices Market Analysis 9.8 China Neurostimulation Devices Market Analysis 9.9 India Neurostimulation Devices Market Analysis 9.10 Australia Neurostimulation Devices Market Analysis 9.11 South Korea Neurostimulation Devices Market Analysis 9.12 Rest of Asia Pacific Neurostimulation Devices Market Analysis
10 Latin America Neurostimulation Devices Market Analysis 10.1 Key Findings 10.2 Latin America Neurostimulation Devices Market Attractiveness Index 10.3 Latin America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn) 10.4 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Country 10.5 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Product 10.6 Latin America Neurostimulation Devices Market Size Estimation and Forecast by Application 10.7 Brazil Neurostimulation Devices Market Analysis 10.8 Mexico Neurostimulation Devices Market Analysis 10.9 Rest of Latin America Neurostimulation Devices Market Analysis
11 MEA Neurostimulation Devices Market Analysis 11.1 Key Findings 11.2 MEA Neurostimulation Devices Market Attractiveness Index 11.3 MEA Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ Mn) 11.4 MEA Neurostimulation Devices Market Size Estimation and Forecast by Country 11.5 MEA Neurostimulation Devices Market Size Estimation and Forecast by Product 11.6 MEA Neurostimulation Devices Market Size Estimation and Forecast by Application 11.7 GCC Neurostimulation Devices Market Analysis 11.8 South Africa Neurostimulation Devices Market Analysis 11.9 Rest of MEA Neurostimulation Devices Market Analysis
12 Company Profiles 12.1 Competitive Landscape, 2021 12.1.1 Medtronic 12.1.2 Boston Scientific Corporation 12.1.3 Abbott Laboratories 12.1.4 LivaNova PLC 12.2 Abbott Laboratories 12.2.1 Company Snapshot 12.2.2 Company Overview 12.2.3 Financial Analysis 12.2.3.1 Net Revenue, 2017-2021 12.2.3.2 R&D, 2017-2021 12.2.3.3 Regional Market Shares, 2021 12.2.4 Product Benchmarking 12.2.5 Strategic Outlook 12.3 Advanced Bionics AG (Sonova) 12.3.1 Company Snapshot 12.3.2 Company Overview 12.3.3 Product Benchmarking 12.3.4 Strategic Outlook 12.4 Boston Scientific Corporation 12.4.1 Company Snapshot 12.4.2 Company Overview 12.4.3 Financial Analysis 12.4.3.1 Net Revenue, 2017-2021 12.4.3.2 R&D, 2017-2021 12.4.3.3 Regional Market Shares, 2021 12.4.4 Product Benchmarking 12.4.5 Strategic Outlook 12.5 BrainCo, Inc 12.5.1 Company Snapshot 12.5.2 Company Overview 12.5.3 Product Benchmarking 12.5.4 Strategic Outlook 12.6 Cochlear Limited 12.6.1 Company Snapshot 12.6.2 Company Overview 12.6.3 Financial Analysis 12.6.3.1 Net Revenue, 2017-2021 12.6.3.2 R&D, 2017-2021 12.6.3.3 Regional Market Shares, 2021 12.6.4 Product Benchmarking 12.6.5 Strategic Outlook 12.7 ElectroCore Inc 12.7.1 Company Snapshot 12.7.2 Company Overview 12.7.3 Financial Analysis 12.7.3.1 Net Revenue, 2017-2021 12.7.3.2 R&D, 2017-2021 12.7.3.3 Regional Market Shares, 2021 12.7.4 Product Benchmarking 12.7.5 Strategic Outlook 12.8 Helbling Holding AG 12.8.1 Company Snapshot 12.8.2 Company Overview 12.8.3 Financial Analysis 12.8.3.1 Net Revenue, 2017-2021 12.8.4 Product Benchmarking 12.8.5 Strategic Outlook 12.9 Innovative Health Solutions, Inc 12.9.1 Company Snapshot 12.9.2 Company Overview 12.9.3 Product Benchmarking 12.9.4 Strategic Outlook 12.10 LivaNova PLC 12.10.1 Company Snapshot 12.10.2 Company Overview 12.10.3 Financial Analysis 12.10.3.1 Net Revenue, 2017-2021 12.10.3.2 R&D, 2017-2021 12.10.3.3 Regional Market Shares, 2021 12.10.4 Product Benchmarking 12.10.5 Strategic Outlook 12.11 Medtronic 12.11.1 Company Snapshot 12.11.2 Company Overview 12.11.3 Financial Analysis 12.11.3.1 Net Revenue, 2017-2021 12.11.3.2 R&D, 2017-2021 12.11.3.3 Regional Market Shares, 2021 12.11.4 Product Benchmarking 12.11.5 Strategic Outlook 12.12 MicroTransponder 12.12.1 Company Snapshot 12.12.2 Company Overview 12.12.3 Product Benchmarking 12.12.4 Strategic Outlook 12.13 Neuronetics, Inc 12.13.1 Company Snapshot 12.13.2 Company Overview 12.13.3 Financial Analysis 12.13.3.1 Net Revenue, 2017-2021 12.13.3.2 R&D, 2017-2021 12.13.3.3 Regional Market Shares, 2021 12.13.4 Product Benchmarking 12.13.5 Strategic Outlook 12.14 Nihon Kohden Corporation 12.14.1 Company Snapshot 12.14.2 Company Overview 12.14.3 Financial Analysis 12.14.3.1 Net Revenue, 2017-2021 12.14.3.2 R&D, 2017-2021 12.14.3.3 Regional Market Shares, 2021 12.14.4 Product Benchmarking 12.14.5 Strategic Outlook 12.15 Natus Medical Incorporated 12.15.1 Company Snapshot 12.15.2 Company Overview 12.15.3 Product Benchmarking 12.15.4 Strategic Outlook 12.16 Parasym Ltd. 12.16.1 Company Snapshot 12.16.2 Company Overview 12.16.3 Product Benchmarking 12.16.4 Strategic Outlook 12.17 Synapse Biomedical Inc 12.17.1 Company Snapshot 12.17.2 Company Overview 12.17.3 Product Benchmarking 12.17.4 Strategic Outlook 12.18 tVNS Technologies GmbH (Cerbomed) 12.18.1 Company Snapshot 12.18.2 Company Overview 12.18.3 Product Benchmarking 12.18.4 Strategic Outlook
13 Conclusion and Recommendations 13.1 Concluding Remarks from Visiongain 13.2 Recommendations for Market Players
List of Tables Table 1 Neurostimulation Devices Market Snapshot, 2023 & 2033 (US$ million, CAGR %) Table 2 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario Table 3 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario Table 4 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario Table 5 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario Table 6 Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 7 Deep Brain Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 8 Gastric Electric Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 9 Spinal Cord Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 10 Sacral Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 11 Vagus Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 12 Transcutaneous Electrical Nerve Stimulation (TENS)Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 13 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 14 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 15 Pain Management Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 16 Epilepsy Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 17 Essential Tremor Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 18 Urinary and Fecal Incontinence Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 19 Depression Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 20 Dystonia Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 21 Gastroparesis Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 22 Parkinson’s Disease Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 23 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 24 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 25 North America Neurostimulation Devices Market Forecast by Country Table 26 North America Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 27 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 28 U.S. Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %) Table 29 Canada Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %) Table 30 Europe Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%) Table 31 Europe Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 32 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 33 Germany Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 34 France Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 35 UK Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 36 Italy Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 37 Spain Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 38 Russia Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 39 Rest of Europe Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 40 Asia Pacific Neurostimulation Devices Market forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%) Table 41 Asia Pacific Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 42 Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 43 Japan Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 44 China Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 45 India Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 46 Australia Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 47 South Korea Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 48 Rest of Asia Pacific Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 49 Latin America Neurostimulation Devices Market Forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%) Table 50 Latin America Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 51 Latin America Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 52 Brazil Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 53 Mexico Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 54 Rest of Latin America Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 55 MEA Neurostimulation Devices forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%) Table 56 MEA Neurostimulation Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 57 MEA Neurostimulation Devices Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 58 GCC Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 59 South Africa Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 60 Rest of MEA Neurostimulation Devices Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) Table 61 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 62 Abbott Laboratories: Product Benchmarking Table 63 Abbott Laboratories: Strategic Outlook Table 64 Advanced Bionics AG (Sonova): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 65 Advanced Bionics AG (Sonova).: Product Benchmarking Table 66 Advanced Bionics AG (Sonova).: Strategic Outlook Table 67 Boston Scientific Corporation, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 68 Boston Scientific Corporation: Product Benchmarking Table 69 Boston Scientific Corporation: Strategic Outlook Table 70 BrainCo, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 71 BrainCo, Inc.: Product Benchmarking Table 72 BrainCo, Inc.: Strategic Outlook Table 73 Cochlear Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 74 Cochlear Limited: Product Benchmarking Table 75 Cochlear Limited: Strategic Outlook Table 76 ElectroCore Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 77 ElectroCore Inc.: Product Benchmarking Table 78 ElectroCore Inc.: Strategic Outlook Table 79 Helbling Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 80 Helbling Holding AG: Product Benchmarking Table 81 Helbling Holding AG: Strategic Outlook Table 82 Innovative Health Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 83 Innovative Health Solutions: Product Benchmarking Table 84 Innovative Health Solutions: Strategic Outlook Table 85 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 86 LivaNova PLC: Product Benchmarking Table 87 LivaNova PLC: Strategic Outlook Table 88 Medtronic: (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 89 Medtronic: Product Benchmarking Table 90 Medtronic: Strategic Outlook Table 91 MicroTransponder: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 92 MicroTransponder: Product Benchmarking Table 93 MicroTransponder: Strategic Outlook Table 94 Neuronetics, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 95 Neuronetics, Inc.: Product Benchmarking Table 96 Neuronetics, Inc.: Strategic Outlook Table 97 Nihon Kohden Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 98 Nihon Kohden Corporation: Product Benchmarking Table 99 Nihon Kohden Corporation: Strategic Outlook Table 100 Natus Medical Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 101 Natus Medical Incorporated: Product Benchmarking Table 102 Natus Medical Incorporated: Strategic Outlook Table 103 Parasym Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 104 Parasym Ltd.: Product Benchmarking Table 105 Parasym Ltd.: Strategic Outlook Table 106 Synapse Biomedical Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 107 Synapse Biomedical Inc.: Product Benchmarking Table 108 Synapse Biomedical Inc.: Strategic Outlook Table 109 tVNS Technologies GmbH (Cerbomed): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 110 tVNS Technologies GmbH (Cerbomed).: Product Benchmarking Table 111 tVNS Technologies GmbH (Cerbomed).: Strategic Outlook
List of Figures Figure 1 Neurostimulation Devices Market Segmentation Figure 2 Neurostimulation Devices Market by Product: Market Attractiveness Index Figure 3 Neurostimulation Devices Market by Application: Market Attractiveness Index Figure 4 Neurostimulation Devices Market Attractiveness Index by Region Figure 5 Neurostimulation Devices Market: Market Dynamics Figure 6 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Figure 7 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Figure 8 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Figure 9 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Figure 10 Neurostimulation Devices Market: Porter’s Five Forces Analysis Figure 11 Neurostimulation Devices Market: PEST Analysis Figure 12 Neurostimulation Devices Market by Product: Market Attractiveness Index Figure 13 Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million) Figure 14 Neurostimulation Devices Market Share Forecast by Product, 2023, 2033 (%) Figure 15 Deep Brain Stimulator Market Forecast by Region, 2023-2033 (US$ million) Figure 16 Deep Brain Stimulator Market Share Forecast by Region, 2023 & 2033 (%) Figure 17 Gastric Electric Stimulator Market Forecast by Region, 2023-2033 (US$ million) Figure 18 Gastric Electric Stimulator Market Share Forecast by Region, 2023 & 2033 (%) Figure 19 Spinal Cord Stimulator Market Forecast by Region, 2023-2033 (US$ million) Figure 20 Spinal Cord Stimulator Market Share Forecast by Region, 2023 & 2033 (%) Figure 21 Sacral Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ million) Figure 22 Sacral Nerve Stimulator Market Share Forecast by Region, 2023 & 2033 (%) Figure 23 Vagus Nerve Stimulator Market Forecast by Region, 2023-2033 (US$ million) Figure 24 Vagus Nerve Stimulator Market Share Forecast by Region, 2023 & 2033 (%) Figure 25 Transcutaneous Electrical Nerve Stimulation (TENS) Market Forecast by Region, 2023-2033 (US$ million) Figure 26 Transcutaneous Electrical Nerve Stimulation (TENS) Market Share Forecast by Region, 2023 & 2033 (%) Figure 27 Others Market Forecast by Region, 2023-2033 (US$ million) Figure 28 Others Market Share Forecast by Region, 2023 & 2033 (%) Figure 29 Neurostimulation Devices Market by Application: Market Attractiveness Index Figure 30 Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million) Figure 31 Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%) Figure 32 Pain Management Market Forecast by Region, 2023-2033 (US$ million) Figure 33 Pain Management Market Share Forecast by Region, 2023 & 2033 (%) Figure 34 Epilepsy Market Forecast by Region, 2023-2033 (US$ million) Figure 35 Epilepsy Market Share Forecast by Region, 2023 & 2033 (%) Figure 36 Essential Tremor Market Forecast by Region, 2023-2033 (US$ million) Figure 37 Essential Tremor Market Share Forecast by Region, 2023 & 2033 (%) Figure 38 Urinary and Fecal Incontinence Market Forecast by Region, 2023-2033 (US$ million) Figure 39 Urinary and Fecal Incontinence Market Share Forecast by Region, 2023 & 2033 (%) Figure 40 Depression Market Forecast by Region, 2023-2033 (US$ million) Figure 41 Depression Market Share Forecast by Region, 2023 & 2033 (%) Figure 42 Dystonia Market Forecast by Region, 2023-2033 (US$ million) Figure 43 Dystonia Market Share Forecast by Region, 2023 & 2033 (%) Figure 44 Gastroparesis Market Forecast by Region, 2023-2033 (US$ million) Figure 45 Gastroparesis Market Share Forecast by Region, 2023 & 2033 (%) Figure 46 Parkinson’s Disease Market Forecast by Region, 2023-2033 (US$ million) Figure 47 Parkinson’s Disease Market Share Forecast by Region, 2023 & 2033 (%) Figure 48 Others Market Forecast by Region, 2023-2033 (US$ million) Figure 49 Others Market Share Forecast by Region, 2023 & 2033 (%) Figure 50 Neurostimulation Devices Market by Region: Market Attractiveness Index Figure 51 Neurostimulation Devices Market by Region, 2023-2033 (US$ Mn) Figure 52 Neurostimulation Devices Market Share Forecast by Region 2023, 2033(%) Figure 53 North America Neurostimulation Devices Market Attractiveness Index Figure 54 North America Neurostimulation Devices Market by Region, 2022, 2027 & 2032 (US$ million) Figure 55 North America Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million) Figure 56 North America Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%) Figure 57 North America Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million) Figure 58 North America Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%) Figure 59 North America Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million) Figure 60 North America Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%) Figure 61 U.S. Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 62 Canada Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 63 Europe Neurostimulation Devices Market Attractiveness Index Figure 64 Europe Neurostimulation Devices Market by Region, 2022, 2027 & 2032 (US$ million) Figure 65 Europe Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million) Figure 66 Europe Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%) Figure 67 Europe Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million) Figure 68 Europe Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%) Figure 69 Europe Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million) Figure 70 Europe Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%) Figure 71 Germany Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 72 France Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 73 UK Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 74 Italy Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 75 Spain Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 76 Russia Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 77 Rest of Europe Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 78 Asia Pacific Neurostimulation Devices Market Attractiveness Index Figure 79 Asia Pacific Neurostimulation Devices Market by Region, 2022, 2027 & 2032 (US$ million) Figure 80 Asia Pacific Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 81 Asia Pacific Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%) Figure 82 Asia Pacific Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million, AGR %) Figure 83 Asia Pacific Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%) Figure 84 Asia Pacific Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million, AGR %) Figure 85 Asia Pacific Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%) Figure 86 Japan Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 87 China Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 88 India Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 89 Australia Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 90 South Korea Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 91 Rest of Asia Pacific Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 92 Latin America Neurostimulation Devices Market Attractiveness Index Figure 93 Latin America Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ million) Figure 94 Latin America Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million) Figure 95 Latin America Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%) Figure 96 Latin America Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million) Figure 97 Latin America Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%) Figure 98 Latin America Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million) Figure 99 Latin America Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%) Figure 100 Brazil Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 101 Mexico Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 102 Rest of Latin America Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 103 MEA Neurostimulation Devices Market Attractiveness Index Figure 104 MEA Neurostimulation Devices Market by Country, 2022, 2027 & 2032 (US$ million) Figure 105 MEA Neurostimulation Devices Market Forecast by Country, 2023-2033 (US$ million) Figure 106 MEA Neurostimulation Devices Market Share Forecast by Country, 2023 & 2033 (%) Figure 107 MEA Neurostimulation Devices Market Forecast by Product, 2023-2033 (US$ million) Figure 108 MEA Neurostimulation Devices Market Share Forecast by Product, 2023 & 2033 (%) Figure 109 MEA Neurostimulation Devices Market Forecast by Application, 2023-2033 (US$ million) Figure 110 MEA Neurostimulation Devices Market Share Forecast by Application, 2023 & 2033 (%) Figure 111 GCC Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 112 South Africa Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 113 Rest of MEA Neurostimulation Devices Market Forecast, 2023-2033 (US$ million, AGR %) Figure 114 Company Share Analysis, 2021 Figure 115 Abbott Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 116 Abbott Laboratories: R&D, 2017-2021 (US$ million, AGR%) Figure 117 Abbott Laboratories: Regional Market Shares, 2021 Figure 118 Boston Scientific Corporation.: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 119 Boston Scientific Corporation.: R&D, 2017-2021 (US$ million, AGR%) Figure 120 Boston Scientific Corporation: Regional Market Shares, 2021 Figure 121 Cochlear Limited: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 122 Cochlear Limited.: R&D, 2017-2021 (US$ million, AGR%) Figure 123 Cochlear Limited.: Regional Market Shares, 2021 Figure 124 ElectroCore Inc.: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 125 ElectroCore Inc.: R&D, 2017-2021 (US$ million, AGR%) Figure 126 ElectroCore Inc.: Regional Market Shares, 2021 Figure 127 Helbling Holding AG: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 128 LivaNova PLC: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 129 LivaNova PLC.: R&D, 2017-2021 (US$ million, AGR%) Figure 130 LivaNova PLC.: Regional Market Shares, 2021 Figure 131 Medtronic: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 132 Medtronic.: R&D, 2017-2021 (US$ million, AGR%) Figure 133 Medtronic.: Regional Market Shares, 2021 Figure 134 Neuronetics, Inc: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 135 Neuronetics, Inc.: R&D, 2017-2021 (US$ million, AGR%) Figure 136 Neuronetics, Inc.: Regional Market Shares, 2021 Figure 137 Nihon Kohden Corporation: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 138 Nihon Kohden Corporation: R&D, 2017-2021 (US$ million, AGR%) Figure 139 Nihon Kohden Corporation: Regional Market Shares, 2021
List of Companies Profiled in the Report Abbott Laboratories Boston Scientific Corporation ElectroCore Inc. Helbling Holding AG Innovative Health Solutions, Inc. LivaNova PLC Medtronic MicroTransponder Neuronetics, Inc. Parasym Ltd. Synapse Biomedical Inc tVNS Technologies GmbH (Cerbomed)
List of Other Companies Mentioned in the Report Axonics Baybe GmbH Blackrock Neurotech Brain Navi Biotechnology Co. Ltd Brainomix Cala DyAnsys Ethicon Helius Medical Technologies, Inc INBRAIN Neuroelectronics S.L Knight Therapeutics Medicrea Neiry Neumora Therapeutics, Inc Neurolief NeuroMetrix Obsidio, Inc Oticon Medical Pediatrix Therapeutics Precisis GmbH Processa Pharmaceuticals ReCor Medical Rune Labs Sinaptica Therapeutics, Inc., SK Life Science, Inc Stimwave Technologies Sunovion Pharmaceuticals Inc. Takeda Theranica Tris Pharma, Inc Voyager Therapeutics
List of Associations Mentioned in the Report American Chronic Pain Association Brain Injury Alliance of New Mexico Brain Injury Association of America Brazilian Neuromodulation Society Canadian Neuromodulation Society Centers for Disease Control and Prevention (CDC) Chinese Neuromodulation Society Defense Logistics Agency (DLA) European Brain Council European Centers for Disease Control and Prevention (ECDC) International Society for ECT and Neurostimulation Japan Society of Pain Latin America and the Caribbean Consortium on Dementia (LAC-CD) National Center for Biotechnology Information National Institute of Health (NIH) North America Neuromodulation Society Saudi Stroke Association South Africa Neuromodulation Society South African Spine Society Southern African Neuroscience Society (SANS) Spanish Pain Association The Japanese Society of Neuropathology The Neuromodulation Society of India The U.S. Food and Drug Administration (FDA) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Neurostimulation Devices Market Report 2023-2033
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
